Mor Zada

Post Doctoral Fellow at @IdoAmitLab of immunu-genomics, @WeizmannScience.
Mechanisms of tumor resistance, early detection, prediction & stratification in MM.

[Mor Zada @MorZada3]

Thrilled to see our study published in @NatureGenet! We pushed the limits of scale to map multiple myeloma heterogeneity across 427 samples, integrating a double layer framework to decode the complexity of the disease. So proud to have led this research with the @IdoAmitLab.

[IdoAmitLab @IdoAmitLab]

Does scale limit what we can discover?
In our new @NatureGenet study, led by @MorZada3 & @Anna_Kurilovich, we built a 427-sample single-cell atlas of multiple myeloma across 341 individuals, linked to genetics and detailed clinical data 🧵 (1/15)
🔗 https://t.co/6XusMDMDN8

[Mor Zada @MorZada3]

@tuchfeld אתה בור ועם הארץ. למדת ביולוגיה? למדת בכלל משהו חוץ מגמרא? אם היית לומד ומשכיל היית יודע שזה לא נכון. שום 40 יום ושום נשמה. תפסיק להפיץ שקרים, זה פייק ניוז.

[Mor Zada @MorZada3]

Awesome project and amazing science, proud to be part of it

[IdoAmitLab @IdoAmitLab]

A super fun collaboration with the Zelzer lab on limb development

[. @IreneGhobrial]

Finally new classification. Myeloma is not one disease #mmsm

[IdoAmitLab @IdoAmitLab]

Happy Purim from the Amit lab!

[Cancer Cell @Cancer_Cell]

Online Now: Intratumoral plasma cells: More than a predictive marker of response to anti-PD-L1 treatment in lung cancer? https://t.co/heremM0dQE

[IdoAmitLab @IdoAmitLab]

Decade-long leukemia remissions with persistence of CD4+ CAR T cells | Nature

https://t.co/abiDmfXRTw

[Cancer Cell @Cancer_Cell]

Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation https://t.co/baLOGYexHg

[Nature Rev Immunol @NatRevImmunol]

A pan-cancer signature for dysfunctional T cells https://t.co/UmrTLTB2Qa

[Cancer Cell @Cancer_Cell]

Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells https://t.co/H4x7vw0jxS

[Cancer Cell @Cancer_Cell]

Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification https://t.co/8r6bjJChB9

[Science Magazine @ScienceMagazine]

Outreach by transgender scientists has highlighted the importance of respecting authors’ privacy and autonomy in correcting the scientific record. Earlier this year, Science established a new name-change policy. Learn more: https://t.co/ecldSlNHdh #TransAwarenessWeek

[IdoAmitLab @IdoAmitLab]

Who said libraries have to be quiet? 😉

[Pavan Bachireddy @pbachi]

1/ Excited to share how T cell therapies kill #leukemia!! multi-omics + new #computational #singlecell tools for longitudinal analysis 👉unexpected answer! https://t.co/t3scnSunRY

*👏* @elhamazizi! 🙏 @dpeer Cathy Wu @MDAndersonNews @CPRITTexas @ColumbiaBME @sloan_kettering

[Nature Immunology @NatImmunol]

Tumor-associated macrophages (TAMs) support an immunosuppressive tumor microenvironment. Di Conza et al. uncover how ER stress responses pathways are engaged to orchestrate pro-tumorigenic features and survival in TAMs by tumor-derived lipids. https://t.co/Ky8n864SXP @PCHo_Lab

[Arthur Mortha @nkg2d1]

Happy to share a new preprint by the best collaborators on this planet and #theonlylabever. We show that "Anti-GM-CSF autoantibodies promote a pre-diseased state in Crohn's Disease" years before diagnosis.
https://t.co/JKEh1nvH8V
Read it, RT and let us know what you think!

[Joao Monteiro @JMinImmunoland]

Amazonas state in Brazil has been hit hard by #COVID19 pandemic. New research shows it has lost 60.4% of the improvements in life expectancy at birth that had been accrued since 2000. Overall mortality in the country as whole is back to levels seen 20 yrs ago.

[IdoAmitLab @IdoAmitLab]

We are very excited to share our new study identifying resistance pathways and therapeutic targets in relapsed multiple myeloma lead by @MorZada3, @MoonspiriTYin, and @AssafWeiner @WeizmannScience https://t.co/JEy9KryJDN (1/14).

[Mor Zada @MorZada3]

@yaircherki מקומו בכלא, לא במערכה רביעית. מקומו בתא נעול וחשוך, לא בעמדה לבצע עבירות מס בתור "נבחר ציבור". באיזה עולם אסיר משוחרר מבצע עבירות, קטנות כגדולות, ואנשים מן השורה הופכים אותו לקורבן? תתבייש לך.

[Mor Zada @MorZada3]

@ishmuli למה הצבעת נגד חוק הפונדקאות? אפס